Licensed Master Social Worker (LMSW) Quiz: Identify Psychotropic Medications
19 questions · exam conditions
0:00
Identify Psychotropic MedicationsQuestion 1 of 19

A client reports feeling restless and unable to sit still after starting an antipsychotic medication. These symptoms are MOST likely indicative of which side effect?

Tardive dyskinesia from long-term medication use
Akathisia from medication effects on movement
Dystonia from acute muscle reactions
Akinesia from reduced movement initiation
← Back to quizzes

Licensed Master Social Worker (LMSW) Quiz

Licensed Master Social Worker (LMSW) Quiz: Identify Psychotropic Medications

Practice Identify Psychotropic Medications in Licensed Master Social Worker (LMSW) with focused quiz questions that help you check what you know, review explanations, and build confidence with test-style prompts.

What this quiz covers

This quiz focuses on Identify Psychotropic Medications, giving you a quick way to practice the rules, question types, and explanations that matter most for Licensed Master Social Worker (LMSW).

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

All questions

Question 1

A client reports feeling restless and unable to sit still after starting an antipsychotic medication. These symptoms are MOST likely indicative of which side effect?

  1. Tardive dyskinesia from long-term medication use
  2. Akathisia from medication effects on movement (correct answer)
  3. Dystonia from acute muscle reactions
  4. Akinesia from reduced movement initiation
Explanation: Restlessness and inability to sit still are classic symptoms of akathisia, a form of movement-related side effect caused by antipsychotic medications. Clients often describe feeling like they need to pace or move constantly. Tardive dyskinesia (A) involves involuntary movements, not restlessness. Dystonia (C) involves muscle spasms and abnormal postures. Akinesia (D) is the absence of movement, opposite of what's described.

Question 2

A social worker learns that a client taking selective serotonin reuptake inhibitors (SSRIs) for depression is also taking St. John's wort. What is the PRIMARY concern with this combination?

  1. Decreased effectiveness of the SSRI medication due to herbal interference
  2. Risk of serotonin syndrome from excessive serotonergic activity (correct answer)
  3. Increased sedation and cognitive impairment from combined effects
  4. Liver toxicity from metabolic interactions between substances
Explanation: The combination of SSRIs and St. John's wort can lead to serotonin syndrome, a potentially life-threatening condition caused by excessive serotonin activity. Both substances increase serotonin levels, and their combination can result in dangerous serotonin accumulation. While decreased effectiveness (A) is possible, the greater concern is toxicity. Sedation (C) is not the primary risk with this combination. Liver toxicity (D) is not the main concern with SSRI and St. John's wort interaction.

Question 3

A social worker learns that a client taking carbamazepine requires regular blood monitoring. This monitoring is MOST likely to detect which serious potential complication?

  1. Decreased platelets leading to increased bleeding risk
  2. Dangerous reduction in blood cell production (correct answer)
  3. Elevated white blood cells indicating infection risk
  4. Increased red blood cells causing circulation problems
Explanation: Carbamazepine can cause aplastic anemia, a rare but serious condition where bone marrow fails to produce adequate blood cells. Social workers should understand why regular blood monitoring is critical for clients on this medication to support treatment compliance and coordinate with medical providers. This awareness helps in recognizing why clients may be anxious about lab appointments and the importance of consistent medical follow-up.

Question 4

During a summer heatwave, an outpatient client treated with lithium for bipolar disorder reports intense thirst, nausea, and a coarse hand tremor after completing a long run.

Based on the presentation, what is the social worker's FIRST concern?

  1. Possible lithium toxicity exacerbated by dehydration and sodium loss (correct answer)
  2. Typical serotonin syndrome triggered by exertion in hot weather
  3. Development of akathisia related to prolonged aerobic exercise
  4. Onset of hypertensive urgency requiring immediate beta-blocker treatment
Explanation: When you encounter medication-related symptoms in clinical practice, always consider the specific drug's side effect profile and risk factors that could worsen toxicity. Lithium has a narrow therapeutic window, making toxicity a constant concern, especially when clients engage in activities that affect fluid and electrolyte balance. The correct answer is A because this presentation strongly suggests lithium toxicity. The client shows classic early signs: intense thirst (polydipsia), nausea, and coarse hand tremor. The timing is crucial—these symptoms appeared after prolonged exercise during a heatwave, which causes dehydration and sodium loss through sweating. Since lithium and sodium compete for reabsorption in the kidneys, sodium depletion leads to increased lithium retention and potential toxicity. Option B is incorrect because serotonin syndrome typically presents with hyperthermia, altered mental status, and neuromuscular rigidity—not the specific symptoms described here. Option C misidentifies akathisia, which is restlessness and an urge to move, not tremor, nausea, and thirst. These symptoms also aren't related to exercise duration. Option D incorrectly assumes hypertension without blood pressure data, and the symptoms don't align with hypertensive urgency. For the LMSW exam, remember that lithium toxicity questions often involve scenarios with dehydration, illness, or activities causing fluid loss. Always prioritize client safety when psychotropic medications are involved, and know the early warning signs of toxicity for commonly prescribed psychiatric medications. The combination of medication + physical stressor + specific symptoms should immediately raise toxicity concerns.

Question 5

A client taking phenelzine attends a community potluck featuring aged cheeses and cured meats. Within two hours, the client experiences severe headache and palpitations. Which medical emergency is MOST likely developing?

  1. Hypertensive crisis precipitated by tyramine interaction with an MAOI (correct answer)
  2. Neuroleptic malignant syndrome from abrupt antipsychotic withdrawal
  3. Pancreatitis secondary to fatty-food ingestion while on valproate
  4. Serotonin discontinuation syndrome from missing a scheduled SSRI dose
Explanation: When you encounter medication questions on the LMSW exam, pay close attention to the specific drug class and timing of symptoms, as these provide crucial diagnostic clues. Phenelzine is a monoamine oxidase inhibitor (MAOI) antidepressant that blocks the enzyme responsible for breaking down tyramine, a naturally occurring compound found in aged, fermented, or cured foods. When someone taking an MAOI consumes tyramine-rich foods like aged cheeses and cured meats, tyramine accumulates and triggers massive norepinephrine release, causing dangerous blood pressure spikes. The client's severe headache and palpitations occurring within two hours of eating these specific foods is the classic presentation of a hypertensive crisis from tyramine-MAOI interaction, making A correct. Option B is incorrect because neuroleptic malignant syndrome results from antipsychotic medications, not MAOIs like phenelzine, and typically develops over days rather than hours. Option C fails because the question mentions phenelzine, not valproate, and pancreatitis doesn't typically cause the rapid onset of headache and palpitations described. Option D is wrong because phenelzine is an MAOI, not an SSRI, and serotonin discontinuation syndrome develops over days of missed doses, not hours after eating specific foods. Remember this pattern: MAOI + tyramine-rich foods + rapid onset severe headache/palpitations = hypertensive crisis. This is a medical emergency requiring immediate intervention. For the exam, always match the medication class to its specific side effects and dietary restrictions.

Question 6

A 10-year-old with ADHD has recently started methylphenidate. The caregiver tells the social worker, "My child is eating very little and has lost two pounds in three weeks."

Which explanation should the social worker provide FIRST to the caregiver?

  1. Appetite suppression and weight loss are common stimulant side effects that should be monitored closely (correct answer)
  2. Rapid weight change is rare with methylphenidate and suggests an underlying endocrine disorder
  3. Weight loss indicates the dosage is sub-therapeutic and probably needs to be increased
  4. The change is unrelated to medication; stimulant effects typically appear only after several months
Explanation: When you encounter questions about medication side effects in child cases, focus on providing accurate, evidence-based information that helps caregivers make informed decisions while emphasizing safety monitoring. Appetite suppression and weight loss are well-documented, common side effects of methylphenidate and other ADHD stimulants. These effects typically occur early in treatment as the medication affects neurotransmitters that regulate appetite. A two-pound weight loss in three weeks warrants close monitoring but falls within the expected range of stimulant side effects. The social worker should first normalize this experience while emphasizing the importance of ongoing observation. Looking at the incorrect options: Option B is wrong because weight loss is actually quite common with methylphenidate, not rare, and jumping to endocrine disorders without considering the obvious medication connection shows poor clinical reasoning. Option C misunderstands pharmacology entirely—weight loss doesn't indicate sub-therapeutic dosing and increasing the dose would likely worsen appetite suppression. Option D contains false information since stimulant effects appear within hours to days, not months, and dismissing the medication connection ignores established side effect profiles. The correct answer is A because it provides accurate information about common stimulant side effects while appropriately emphasizing monitoring—exactly what caregivers need to hear first. For LMSW exam success, remember that when medications are involved, always consider known side effect profiles before suggesting rare conditions or medication adjustments. Your role includes providing accurate psychopharmacological education to support informed decision-making between families and prescribers.

Question 7

A middle-aged client taking sertraline begins self-treating seasonal allergies with over-the-counter dextromethorphan and also starts St. John's wort on a friend's recommendation. Two days later, the client presents with agitation, sweating, and muscle rigidity.

The social worker should suspect which medication-related emergency?

  1. Serotonin syndrome caused by additive serotonergic substances (correct answer)
  2. Neuroleptic malignant syndrome resulting from dopaminergic blockade
  3. Anticholinergic crisis precipitated by herbal supplement interactions
  4. Hypertensive urgency due to stimulant contamination in over-the-counter remedies
Explanation: When you encounter questions about psychiatric medication interactions, focus on identifying the specific neurotransmitter systems involved and recognizing classic symptom patterns of medication-related emergencies. This scenario presents a dangerous drug interaction involving three serotonergic substances. Sertraline is an SSRI that blocks serotonin reuptake, dextromethorphan (a cough suppressant) has serotonergic properties, and St. John's wort acts as a natural serotonin reuptake inhibitor. When combined, these substances create excessive serotonin activity, leading to serotonin syndrome. The classic triad of symptoms—altered mental status (agitation), autonomic dysfunction (sweating), and neuromuscular abnormalities (muscle rigidity)—confirms this diagnosis. Answer A correctly identifies this additive serotonergic effect. Answer B describes neuroleptic malignant syndrome, which occurs with antipsychotic medications that block dopamine receptors. While it shares some symptoms with serotonin syndrome (hyperthermia, rigidity), it's not caused by the medications in this scenario and typically develops more gradually. Answer C suggests anticholinergic crisis, which would present with dry mouth, urinary retention, and confusion—not the sweating and agitation described here. Neither dextromethorphan nor St. John's wort primarily affects cholinergic systems. Answer D incorrectly assumes stimulant contamination, which isn't supported by the scenario and wouldn't explain the muscle rigidity pattern seen in serotonin syndrome. Remember: Always assess for dangerous drug interactions when clients combine prescription medications with over-the-counter drugs and herbal supplements. Serotonin syndrome is a medical emergency requiring immediate intervention.

Question 8

A client with generalized anxiety disorder asks about starting buspirone because a friend "sleeps all day on Xanax and I can't afford that kind of fatigue."

Which statement accurately distinguishes buspirone from benzodiazepines such as alprazolam?

  1. Buspirone produces minimal sedation and lacks abuse potential but requires several weeks for therapeutic effect (correct answer)
  2. Buspirone offers rapid anxiolysis identical to alprazolam yet carries a higher risk of cognitive impairment
  3. Buspirone is contraindicated in anxiety disorders because it acts only on depressive symptoms
  4. Buspirone causes respiratory depression similar to high-dose benzodiazepines and must be taken at bedtime
Explanation: When you encounter medication comparison questions on the LMSW exam, focus on understanding each drug's mechanism, onset, side effect profile, and abuse potential—these are key distinguishing factors social workers need to know for client advocacy and treatment planning. Buspirone and benzodiazepines work through completely different pathways. Buspirone is a serotonin receptor partial agonist that takes 2-4 weeks to reach therapeutic effect, produces minimal sedation, and has virtually no abuse potential. This makes it ideal for clients who need to maintain alertness for work or daily functioning. Benzodiazepines like alprazolam (Xanax) work on GABA receptors, providing rapid relief within 30-60 minutes but causing significant sedation and carrying high abuse potential. Looking at the incorrect options: Choice B is wrong because buspirone doesn't offer rapid anxiolysis—it takes weeks to work and actually has lower cognitive impairment risk than benzodiazepines. Choice C incorrectly states buspirone is contraindicated for anxiety; it's FDA-approved specifically for generalized anxiety disorder and doesn't treat depression. Choice D falsely claims buspirone causes respiratory depression like benzodiazepines—buspirone is much safer and doesn't depress breathing. Choice A correctly identifies buspirone's three key characteristics: minimal sedation (addressing the client's fatigue concern), no abuse potential, and delayed onset requiring several weeks for effect. Study tip: Remember the trade-off between benzodiazepines and buspirone—fast relief with side effects versus slow relief with fewer risks. This distinction frequently appears on social work exams when testing medication knowledge for client consultation.

Question 9

Which side effect is MOST characteristic of tricyclic antidepressants such as amitriptyline and should be discussed during psychoeducation?

  1. Anticholinergic symptoms including dry mouth, constipation, and urinary retention (correct answer)
  2. Dose-related extrapyramidal rigidity frequently requiring antipsychotic dose reduction
  3. Severe hypoglycemia precipitated by increased insulin secretion
  4. Hyponatremia secondary to inappropriate antidiuretic hormone release
Explanation: When you encounter questions about tricyclic antidepressants (TCAs) on the LMSW exam, focus on their distinctive anticholinergic side effect profile, which differs significantly from other antidepressant classes. Answer A is correct because anticholinergic symptoms are the hallmark side effects of TCAs like amitriptyline. These medications block acetylcholine receptors, leading to the classic triad of dry mouth, constipation, and urinary retention. Additional anticholinergic effects include blurred vision, confusion, and sedation. These side effects are dose-dependent, predictable, and occur in most patients taking TCAs, making them essential topics for psychoeducation. Answer B is wrong because extrapyramidal symptoms (muscle rigidity, tremors) are characteristic of antipsychotic medications, not antidepressants. TCAs don't typically cause these movement-related side effects, and the reference to "antipsychotic dose reduction" is irrelevant to TCA treatment. Answer C is incorrect because TCAs don't cause hypoglycemia or affect insulin secretion. While TCAs can cause weight gain and metabolic changes, severe hypoglycemia isn't a recognized side effect. Answer D is wrong because hyponatremia from inappropriate ADH release is most commonly associated with SSRIs (like sertraline or fluoxetine), not tricyclic antidepressants. This side effect occurs when SSRIs disrupt sodium regulation. Study tip: Remember "anticholinergic = anti-SLUDGE" (anti-Salivation, anti-Lacrimation, anti-Urination, anti-Defecation, anti-GI motility, anti-Emesis). When you see TCA questions, think dry mouth, constipation, and urinary retention as the signature side effects requiring patient education.

Question 10

Parents of an adolescent starting escitalopram express concern after reading an online article about suicide.

How should the social worker respond to the parents' concern?

  1. Acknowledge their concern, explain the FDA warning about increased suicidal thoughts in youth, and collaborate on monitoring plans (correct answer)
  2. Reassure them that SSRIs eliminate suicide risk and no extra precautions are needed
  3. Advise that only tricyclic antidepressants affect suicidality in teenagers
  4. State that suicidal ideation is impossible once treatment begins
Explanation: When you encounter questions about antidepressants and suicide risk in adolescents, you're being tested on your knowledge of FDA black box warnings and appropriate clinical responses to parent concerns. The correct response involves validating parental concerns while providing accurate psychoeducation. The FDA issued a black box warning for SSRIs like escitalopram because clinical trials showed increased suicidal thoughts and behaviors in children and adolescents during initial treatment weeks. A competent social worker acknowledges this legitimate concern, explains the warning factually, and collaborates with parents on safety monitoring strategies. This approach maintains therapeutic alliance while ensuring proper oversight. Answer B is dangerously incorrect because SSRIs don't eliminate suicide risk—they can actually increase it initially in young people, which is precisely why the FDA warning exists. Providing false reassurance violates informed consent principles and puts the adolescent at risk. Answer C contains factual errors. The FDA warning applies specifically to SSRIs and other newer antidepressants in youth, not tricyclics. While tricyclics have their own risks, this misrepresents the actual research findings about escitalopram. Answer D is absolutely false and potentially harmful. Suicidal ideation can persist or even increase during early antidepressant treatment, especially in adolescents. This misconception could lead to inadequate monitoring. Remember: LMSW exam questions about psychotropic medications often test whether you understand FDA warnings and can balance honest risk communication with appropriate treatment support. Always validate concerns and provide accurate information rather than false reassurance.

Question 11

A social worker reviews records for a client who abruptly stopped paroxetine five days ago and now reports dizziness, flu-like feelings, and "electric shock" sensations. What phenomenon is the client MOST likely experiencing?

  1. SSRI discontinuation syndrome due to sudden withdrawal (correct answer)
  2. Early signs of tardive dyskinesia emerging post-antidepressant
  3. Initiation phase adverse events from a newly prescribed benzodiazepine
  4. Serotonin syndrome from excess serotonergic activity
Explanation: When you encounter questions about medication side effects and timing, pay close attention to the specific drug involved and the timeline of symptoms. This question tests your knowledge of antidepressant withdrawal effects. The client stopped paroxetine (Paxil), an SSRI, five days ago and is experiencing classic withdrawal symptoms. SSRIs with shorter half-lives like paroxetine are particularly notorious for causing discontinuation syndrome when stopped abruptly. The "electric shock" sensations (often called "brain zaps"), dizziness, and flu-like symptoms are textbook signs of SSRI discontinuation syndrome, which typically begins within 1-3 days of stopping and peaks around day 5-7. Looking at the wrong answers: Option B (tardive dyskinesia) involves involuntary muscle movements and is associated with antipsychotic medications, not antidepressants. Option C mentions benzodiazepine initiation, but there's no indication the client started a new medication—they stopped one. Option D (serotonin syndrome) occurs when there's too much serotonin activity, typically from drug interactions or overdoses, not from stopping medication. The timeline is crucial here: symptoms appearing days after discontinuation point directly to withdrawal, not toxicity or new medication effects. Study tip: Remember the "3 D's" of SSRI discontinuation syndrome: Dizziness, Dysphoria, and "electrical" sensations (brain zaps). Short half-life SSRIs like paroxetine and venlafaxine cause the most severe withdrawal symptoms. Always consider medication timeline when evaluating psychiatric symptoms—what was started, stopped, or changed recently?

Question 12

A 32-year-old client participating in individual therapy reports newly prescribed fluoxetine for treatment-resistant depression. Two weeks later, the client tells the social worker, "My mood is a little better, but something strange is happening—my partner and I tried to be intimate, and I could not reach orgasm."

Given the client's report, which statement BEST explains what is occurring?

  1. Selective serotonin reuptake inhibitors often cause anorgasmia as a dose-dependent side effect (correct answer)
  2. Fluoxetine usually produces temporary impotence that resolves once steady-state blood levels are achieved
  3. Sexual dysfunction only appears with tricyclic antidepressants, suggesting the symptom is unrelated to medication
  4. The symptom indicates tolerance to fluoxetine and typically signals a need for dose escalation
Explanation: When you encounter questions about psychiatric medications and side effects, focus on understanding the major drug classes and their characteristic adverse effects. SSRIs like fluoxetine are among the most commonly prescribed antidepressants, so knowing their side effect profile is essential for the LMSW exam. The client's experience represents a classic SSRI-induced sexual side effect. Fluoxetine and other SSRIs increase serotonin availability in the brain, but this same mechanism affects sexual function. High serotonin levels can interfere with the sexual response cycle, particularly orgasm. This occurs because serotonin generally has an inhibitory effect on sexual arousal and climax. The dose-dependent nature means higher doses typically produce more pronounced sexual side effects, making answer A correct. Answer B incorrectly focuses on impotence and suggests the problem is temporary until steady-state levels are reached. However, anorgasmia (inability to reach orgasm) is different from erectile dysfunction, and sexual side effects often persist rather than resolve with time. Answer C contains a major factual error—sexual dysfunction is actually more common with SSRIs than with tricyclic antidepressants, making this statement backwards. Answer D misinterprets the situation entirely, suggesting tolerance when the client is actually experiencing a known side effect, not reduced therapeutic efficacy. Remember for the exam: SSRIs commonly cause sexual side effects (decreased libido, delayed orgasm, erectile dysfunction), while tricyclics are more associated with anticholinergic effects like dry mouth and constipation. Don't confuse side effects with tolerance or treatment failure.

Question 13

A social worker working with a client taking lithium for bipolar disorder should be aware that regular medical monitoring is essential for which potential complications?

  1. Liver function problems and elevated bilirubin levels
  2. Kidney function decline and thyroid problems (correct answer)
  3. Blood count changes and platelet disorders
  4. Cardiac function issues and cholesterol elevation
Explanation: Social workers should understand that lithium requires regular monitoring of kidney function (potential nephrotoxicity) and thyroid function (potential hypothyroidism). While social workers don't interpret lab results, awareness of these monitoring needs helps in coordinating care and understanding client experiences. This knowledge supports appropriate referrals and collaboration with medical providers.

Question 14

A client with panic disorder has been prescribed benzodiazepines and asks about potential side effects. What should the social worker identify as the MOST significant long-term risk?

  1. Physical dependence and withdrawal syndrome upon discontinuation (correct answer)
  2. Permanent cognitive impairment and memory loss
  3. Liver damage from prolonged metabolic processing
  4. Cardiovascular complications including arrhythmias
Explanation: Physical dependence and potentially dangerous withdrawal symptoms are the most significant long-term risks of benzodiazepines. Tolerance develops quickly, and abrupt discontinuation can cause seizures and life-threatening withdrawal. While cognitive effects (B) can occur, they're typically reversible. Liver damage (C) is less common with benzodiazepines compared to other medications. Cardiovascular complications (D) are not typically associated with benzodiazepine use.

Question 15

A client with schizophrenia taking clozapine mentions having a sore throat and feeling fatigued. What should be the social worker's FIRST concern regarding these symptoms?

  1. Development of tardive dyskinesia requiring medication adjustment
  2. Potential agranulocytosis requiring immediate blood work evaluation (correct answer)
  3. Metabolic syndrome indicating need for lifestyle modifications
  4. Neuroleptic malignant syndrome requiring emergency intervention
Explanation: Sore throat and fatigue in a client taking clozapine are potential early signs of agranulocytosis, a dangerous drop in white blood cells that can be life-threatening. Clozapine requires regular blood monitoring specifically for this reason. Tardive dyskinesia (A) involves involuntary movements, not these symptoms. Metabolic syndrome (C) presents differently with weight gain and metabolic changes. Neuroleptic malignant syndrome (D) involves hyperthermia, rigidity, and altered consciousness.

Question 16

A client taking antipsychotic medication develops involuntary movements of the tongue and facial muscles after several months of treatment. This presentation is MOST consistent with which condition?

  1. Acute dystonia requiring immediate medical intervention
  2. Tardive dyskinesia from long-term medication use (correct answer)
  3. Akathisia indicating need for medication adjustment
  4. Pseudoparkinsonism requiring dosage modification
Explanation: Involuntary movements of the tongue and facial muscles developing after months of antipsychotic treatment are characteristic of tardive dyskinesia, a potentially irreversible condition caused by long-term antipsychotic use. This condition may persist even after medication discontinuation. Acute dystonia (A) occurs rapidly and involves muscle spasms. Akathisia (C) is restlessness and agitation. Pseudoparkinsonism (D) involves tremor, rigidity, and slow movements, not tongue/facial movements.

Question 17

A client with panic disorder taking alprazolam wants to discontinue the medication. What is the MOST important consideration for safe discontinuation?

  1. Immediate cessation to avoid prolonging dependence risk
  2. Gradual tapering to prevent withdrawal seizures (correct answer)
  3. Switching to another benzodiazepine with longer half-life
  4. Increasing dose temporarily before stopping completely
Explanation: Benzodiazepine withdrawal can be life-threatening, particularly for short-acting medications like alprazolam. Abrupt discontinuation can cause withdrawal seizures, so gradual tapering over weeks or months is essential for safety. Immediate cessation (A) is dangerous and can cause seizures. While switching to longer-acting benzodiazepines (C) is sometimes done, gradual tapering is the key principle. Increasing the dose (D) would worsen dependence and is not appropriate.

Question 18

Which laboratory value should a social worker verify has been recently monitored because it is CRITICAL for a client taking clozapine?

  1. Absolute neutrophil count to detect agranulocytosis risk (correct answer)
  2. Serum creatinine to monitor potential nephrotoxicity
  3. Thyroid-stimulating hormone to screen for hypothyroidism
  4. Fasting triglycerides to evaluate pancreatitis risk
Explanation: When you encounter questions about psychiatric medications, always consider the most serious and immediate safety risks that require ongoing monitoring. Clozapine, an atypical antipsychotic used for treatment-resistant schizophrenia, carries a well-established risk of agranulocytosis—a potentially fatal condition where white blood cell counts drop dangerously low, leaving patients vulnerable to life-threatening infections. The correct answer is A because monitoring the absolute neutrophil count (ANC) is mandatory for all patients on clozapine. This monitoring must occur weekly for the first six months, then biweekly for the next six months, and monthly thereafter. If the ANC drops below safe levels, clozapine must be immediately discontinued. This isn't optional—it's a regulatory requirement due to the medication's black box warning. Option B is incorrect because while clozapine can affect kidney function, nephrotoxicity isn't the primary concern requiring critical monitoring. Option C is wrong because thyroid dysfunction, while possible with some psychiatric medications, isn't clozapine's most dangerous side effect. Option D is incorrect because although clozapine can cause metabolic changes including elevated triglycerides, pancreatitis risk doesn't require the same urgent, frequent monitoring as agranulocytosis. Remember this pattern: when you see clozapine in any question, immediately think "blood monitoring for agranulocytosis." This is one of the most important medication safety protocols in psychiatry, and LMSW exams frequently test whether you know which medications require specific monitoring. Always prioritize life-threatening complications over less severe side effects.

Question 19

Which organ system requires baseline and periodic monitoring when a client is prescribed valproic acid for mood stabilization?

  1. Hepatic function because of potential liver toxicity (correct answer)
  2. Pulmonary function because of restrictive lung disease risk
  3. Endocrine function because of frequent adrenal suppression
  4. Renal function because valproate concentrates in the kidneys
Explanation: When you encounter questions about psychotropic medications, always consider the major side effects and monitoring requirements that social workers need to understand for client safety and collaboration with medical professionals. Valproic acid (Depakote) is a mood stabilizer commonly used for bipolar disorder, but it carries significant hepatotoxicity risks. The liver metabolizes valproic acid, and this process can cause serious liver damage, particularly in the first six months of treatment. This is why baseline liver function tests are required before starting treatment, with periodic monitoring throughout. Symptoms of liver toxicity include nausea, vomiting, fatigue, and jaundice - signs that social workers should recognize and report immediately. Looking at the incorrect options: Choice B is wrong because valproic acid doesn't typically cause pulmonary complications or restrictive lung disease. Choice C is incorrect - while valproic acid can affect some hormones (like increasing testosterone in women), adrenal suppression isn't a primary concern requiring routine monitoring. Choice D is misleading because although valproate is partially eliminated through the kidneys, renal toxicity isn't the primary monitoring concern, and the drug doesn't particularly "concentrate" in kidney tissue. The correct answer is A - hepatic function monitoring is essential due to valproic acid's well-documented liver toxicity risk. Study tip: For mood stabilizers on the LMSW exam, remember the "Big Three" monitoring requirements: lithium requires kidney and thyroid monitoring, valproic acid requires liver monitoring, and carbamazepine requires blood count monitoring. This pattern appears frequently in questions about medication management and interdisciplinary collaboration.